A detailed history of Hollencrest Capital Management transactions in Viatris Inc stock. As of the latest transaction made, Hollencrest Capital Management holds 9,568 shares of VTRS stock, worth $103,908. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,568
Previous 9,568 -0.0%
Holding current value
$103,908
Previous $111,000 7.21%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $90,567 - $107,189
9,444 Added 7616.13%
9,568 $94,000
Q1 2023

May 16, 2023

SELL
$9.2 - $12.26 $3,183 - $4,241
-346 Reduced 73.62%
124 $1,000
Q4 2022

Feb 06, 2023

BUY
$8.72 - $11.56 $4,098 - $5,433
470 New
470 $5,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.